We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Statins May Slow the Effects of Alzheimer's Disease

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Cholesterol-lowering drugs like statins were found to slow the progression of Alzheimer's disease (AD) in a three year study of 342 AD patients (J. Neurol. Neurosurg. Psychiatry December, 2005; 76:1624-1629).

Researchers at the University of Lille and the University Hospital, Lille, France compared AD patients taking cholesterol-lowering medication including statins to AD patients with unmedicated high cholesterol levels and to AD patients with normal cholesterol.

They found that the use of cholesterol-lowering medication slowed the cognitive decline that is the hallmark of AD as compared to both the unmedicated high cholesterol group and the normal cholesterol group.

Nymox Pharmaceutical Corporation holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of AD.